Progression of structural damage is not related to rituximab serum levels in rheumatoid arthritis patients

Author(s):: Boumans, M.; Teng, O.; Thurlings, R.; Bijlsma, J.; Gerlag, D.; Huizinga, T.; Vos, K.; Stapel, S.; Wolbink, G.; Tekstra, J.; Laar, J. van; Tak, P.P.

Published: 2013
Publication type: Article / Letter to editor

rheumatoid arthritisbiologicsrituximabB cellsradiology

Date issued: 2013-08-31
Language: English
Is part of: Rheumatology (2013), Vol. 52, no. 8, p. 1462-1466
hdl: 1887/98761
doi: 10.1093/rheumatology/ket137